Pain Control After Lumbar Spine Fusion
Launched by ROTHMAN INSTITUTE ORTHOPAEDICS · Jun 26, 2024
Trial Information
Current as of July 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥18 years of age, ≥1-level planned lumbar spinal fusion
- • Capacity to enroll
- • English speaking
- Exclusion Criteria:
- • Chronic kidney disease (preoperative creatinine ≥1.4)
- • History of gastrointestinal bleed or peptic ulcer disease
- • History of spinal fusion nonunion
- • Non-steroidal anti-inflammatory drug allergy
- • Previously diagnosed coagulopathy
- • Preoperative thrombocytopenia (platelets \<100,000)
- • Connective tissue disease
- • Operative indication due to infection, neoplasm, or trauma
- • Currently pregnant
About Rothman Institute Orthopaedics
Rothman Institute Orthopaedics is a leading healthcare organization specializing in orthopedic care and research. With a commitment to advancing the field of orthopedics, Rothman Institute conducts innovative clinical trials aimed at improving patient outcomes and enhancing treatment methodologies. Renowned for its team of highly skilled orthopedic surgeons and researchers, the institute integrates cutting-edge technology and evidence-based practices to deliver exceptional care. Through its rigorous research initiatives, Rothman Institute is dedicated to fostering advancements in orthopedic medicine and contributing to the overall improvement of musculoskeletal health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported